Hypertension Clinical Trial
Official title:
A Self-Administered Mobile Phone-based Holistic Intervention for Promoting Healthy Habits and Weight Loss in People Who Are Overweight or Obese
A self administered 16 weeks plus follow up study to explore the efficacy of mobile phone driven apps for stress reduction coupled with guidance for healthy living among obese and overweight populations. The Study primary end points are weight of the participants, as well as glucose measurements (for subject with diabetes) and blood pressure (of subjects with hypertension).
Status | Recruiting |
Enrollment | 500 |
Est. completion date | October 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Be 18 years of age or older and - have a body mass index (BMI) of at least 24 kg/m2 (22 kg/m2 if Asian) and - be able to engage in light physical activity Exclusion Criteria: - no Internet access or use of iOS - taking more than three antihypertensive or diabetes drugs; meeting the DSM-5 criteria for an eating disorder - having a disability that prevents or hinders exercise and physical activity - receiving any treatment for weight loss elsewhere. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Mt Sinai Medical Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Eco Fusion |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BMI | 16 weeks | No | |
Primary | Glucose level | 16 weeks | No | |
Primary | blood pressure | 16 weeks | No | |
Primary | BMI | 6 months | No | |
Primary | BMI | 12 months | No | |
Primary | glucose level | 6 months | No | |
Primary | glucose level | 12 months | No | |
Primary | blood pressure | 6 months | No | |
Primary | blood pressure | 12 months | No | |
Secondary | Quality of Life questionnaire | 16 weeks | No | |
Secondary | Quality of Life questionnaire | 6 months | No | |
Secondary | Quality of Life questionnaire | 12 months | No | |
Secondary | Burnout measure | 16 weeks | No | |
Secondary | Burnout Measure | 6 months | No | |
Secondary | Burnout measure | 12 months | No | |
Secondary | Perceived dietary adherence questionnaire | 16 weeks | No | |
Secondary | Perceived dietary adherence questionnaire | 6 months | No | |
Secondary | Perceived dietary adherence questionnaire | 12 months | No | |
Secondary | Mind wandering index | tendency and frequency of mind wandering | 16 weeks | No |
Secondary | Mind wandering index | 6 months | No | |
Secondary | Mind wandering index | 1 year | No | |
Secondary | stress mindset scale | 16 weeks | No | |
Secondary | stress mindset scale | 6 months | No | |
Secondary | stress mindset scale | 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |